San Francisco Bay Area biotech stories.
Wednesday, July 20, 2011
Dynavax hepatitis B vaccine effective but lots inconsistent
Shares of Dynavax Technologies Corp.plummeted 19 percent Wednesday after the Berkeley company company said its hepatitis B virus vaccine bested a current treatment but said lots of the vaccine were inconsistent.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)